843 related articles for article (PubMed ID: 32521159)
1. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
[TBL] [Abstract][Full Text] [Related]
3. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
4. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.
Arba M; Wahyudi ST; Brunt DJ; Paradis N; Wu C
Comput Biol Med; 2021 Feb; 129():104156. PubMed ID: 33260103
[TBL] [Abstract][Full Text] [Related]
6. Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
Gao Y; Yan L; Huang Y; Liu F; Zhao Y; Cao L; Wang T; Sun Q; Ming Z; Zhang L; Ge J; Zheng L; Zhang Y; Wang H; Zhu Y; Zhu C; Hu T; Hua T; Zhang B; Yang X; Li J; Yang H; Liu Z; Xu W; Guddat LW; Wang Q; Lou Z; Rao Z
Science; 2020 May; 368(6492):779-782. PubMed ID: 32277040
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
[TBL] [Abstract][Full Text] [Related]
8. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
[TBL] [Abstract][Full Text] [Related]
9. Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation.
Kato K; Honma T; Fukuzawa K
J Mol Graph Model; 2020 Nov; 100():107695. PubMed ID: 32702590
[TBL] [Abstract][Full Text] [Related]
10. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
Nguyen HL; Thai NQ; Truong DT; Li MS
J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
[TBL] [Abstract][Full Text] [Related]
12. Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex.
Olotu FA; Omolabi KF; Soliman MES
Cell Biochem Biophys; 2021 Jun; 79(2):175-187. PubMed ID: 33792836
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
14. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Elfiky AA
Life Sci; 2020 May; 248():117477. PubMed ID: 32119961
[TBL] [Abstract][Full Text] [Related]
15. Structure of replicating SARS-CoV-2 polymerase.
Hillen HS; Kokic G; Farnung L; Dienemann C; Tegunov D; Cramer P
Nature; 2020 Aug; 584(7819):154-156. PubMed ID: 32438371
[TBL] [Abstract][Full Text] [Related]
16. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
Wang Y; Li P; Rajpoot S; Saqib U; Yu P; Li Y; Li Y; Ma Z; Baig MS; Pan Q
Sci Rep; 2021 Dec; 11(1):23465. PubMed ID: 34873274
[TBL] [Abstract][Full Text] [Related]
18. 1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication.
Zhang L; Zhang D; Wang X; Yuan C; Li Y; Jia X; Gao X; Yen HL; Cheung PP; Huang X
Phys Chem Chem Phys; 2021 Mar; 23(10):5852-5863. PubMed ID: 33688867
[TBL] [Abstract][Full Text] [Related]
19. Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV.
Singh PK; Pathania S; Rawal RK
SAR QSAR Environ Res; 2020 Nov; 31(11):857-867. PubMed ID: 33100032
[TBL] [Abstract][Full Text] [Related]
20. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir.
Banerjee A; Kanwar M; Maiti S
Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
